Background: Calls for improvement in end-of-life care have focused attention on the management of pain and other troubling symptoms at the end of life.
I
n a seminal 1997 report on the state of end-of-life care, the Institute of Medicine described extensive patient and family suffering and emphasized the need for better care at the end of life (1) . Subsequent activity included the development of guidelines and quality measures and the growth of palliative medicine, including clinical training programs (2) (3) (4) (5) . Policy and practice emphasized better pain management (6) . Hospice use doubled from 2000 to 2009, with 42% of Americans receiving hospice care before death in 2009 (7) .
Symptoms are among the most distressing aspects of the end-of-life experience for patients and families; interventions often promote comfort across a range of conditions and symptoms (2, 8 -11) . Although we lack definitive population-based data, systematic reviews have shown the high prevalence of many symptoms, including pain, dyspnea, and depression, across many advanced diseases (12) . Pain is one of the most prevalent and troubling symptoms, and patients and families fear it and wish to avoid it near the end of life (13, 14) .
It is not known whether national efforts to improve end-of-life care since the Institute of Medicine report have led to changes in the prevalence of commonly occurring end-of-life symptoms. We therefore examined nationally representative trends in end-of-life symptom prevalence from 1998 to 2010 for the whole population and for different groups of decedents. Given the strength of practice evidence and policy attention to both cancer and pain (6, 15), we expected that overall trends would be better for patients with cancer than for those with other conditions, and that trends in the prevalence and severity of pain would be better than for other symptoms.
METHODS

Setting and Study Participants
We used data from the HRS (Health and Retirement Study), a nationally representative longitudinal survey of community-dwelling adults aged 51 years or older in the contiguous United States (16, 17) . The mortality rate of the HRS population is similar to that of the overall U.S. population of adults aged 51 years or older. The HRS participants are interviewed every 2 years until their deaths. After each participant's death, study staff interview a proxy informant (typically a family member) who is most familiar with the health, family, and financial situation of the participant. We included participants who died while enrolled in the HRS and whose household income. Proxy covariates included the relationship of the proxy to the decedent (spouse, son or daughter, or other); time elapsed between the decedent's death and the proxy's interview; average hours of care given per week to the decedent from all informal caregivers, including by the proxy; highest education level (only available if the proxy was the decedent's spouse [approximately 33% of proxies]); and English or Spanish preference for the interview. We also included the year that the decedent entered the HRS sample.
Decedent Categories
We used a sequential categorization scheme based on prior work to place decedents into 4 mutually exclusive categories: sudden death, cancer, congestive heart failure (CHF) or chronic lung disease, and frailty (20 -23) . Decedents were categorized as "sudden death" if they died within 1 day of receiving their terminal diagnosis; "cancer" if their proxy reported cancer as the cause of death; "CHF or chronic lung disease" if they or their proxy reported a diagnosis of either or both of these conditions; or "frailty" if they died in a nursing home, they or their proxy reported physiciandiagnosed memory impairment, or their proxy reported hip fracture in the last 2 years of life.
Questions about diagnoses of CHF, chronic lung disease, and physician-diagnosed memory impairment were presented to proxies in postmortem interviews and to decedents in each survey wave while they were alive. We considered each condition to be present if either the decedent or the proxy reported its presence.
Statistical Analysis
All analyses accounted for complex survey design by using sampling weights, which provided estimates representative of the entire U.S. population. We used multivariable logistic regression models to investigate the association between each symptom outcome and time of death. We used 2 sets of models for each outcome: a fully adjusted model that included all symptom covariates previously described, and a minimally adjusted model that included only demographic characteristics and time elapsed between the decedent's death and the proxy's interview. We conducted all analyses for the cohort as a whole and in each of the 4 mutually exclusive decedent categories. All decedents were included in the entire population analysis, and decedents who were placed into 1 of the 4 categories were also analyzed separately in that category.
We report the adjusted prevalence of each symptom by year of death from the fully and minimally adjusted models. The percentage of change in the adjusted prevalence of each symptom was estimated by using the first and last dates of death from all regressions, and bootstrapping with bias correction was used to estimate CIs (24) . We report the adjusted percentage of change in the prevalence of each symptom from the fully and minimally adjusted models.
Symptom outcomes were missing for 0.1% (frequent vomiting) to 3.3% (pain) of decedents. Eleven symptom covariates were incompletely reported, with rates of missing outcomes ranging from 0.0006% (diag-
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Symptom Trends in the Last Year of Life nosis of arthritis) to 8.1% (number of nights spent in a hospital in the last 2 years of life). We used the ice command in Stata/IC, version 12.1 (StataCorp) (25) , to impute missing values through multiple imputation by chained equations with 15 imputed data sets; we analyzed imputed data with the mi estimate commands in Stata/IC or manually by using the Rubin rules (26) . We constructed a multiple imputation model that included time of death, decedent categories, all symptom outcome variables, and all symptom covariates described earlier except the year that the decedent entered the HRS sample. Two sets of variables were imputed in forms different from those included in the regression analyses. First, pain was captured with 1 categorical variable that recorded no pain or mild, moderate, or severe pain, and the outcomes of any pain and moderate or severe pain were created from this categorical variable after imputation. Second, the 6 activities of daily living questions were included separately in the imputation model and combined into a scale after imputation.
In the 2002 survey wave only, approximately 41% of the proxies were erroneously not asked nonpain symptom questions because of faulty survey logic. On discovering the issue, staff corrected the survey logic but did not go back and collect the missing data. As a result, those responses were permanently lost. In our primary analyses, we excluded proxies in the 2002 survey wave with missing symptom questions. In a sensitivity analysis, we replicated these analyses after excluding the entire 2002 survey wave to investigate the effect of potentially nonrandom missing data due to faulty survey logic.
We also performed an additional sensitivity analysis to evaluate whether there was substantial year-toyear variation in our outcomes. We replicated each minimally adjusted multivariable logistic regression using a continuous variable that captured each survey year rather than a variable that captured time of death. We report the average yearly percentage of change and CIs.
We conducted all analyses with Stata/IC, version 12.1. The RAND Institutional Review Board approved the study.
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RESULTS
From 1998 to 2010, a total of 8641 HRS participants died and 8089 proxy interviews were completed. Of those, 7204 interviews were completed within 2 years of the decedent's death; these were included in our study cohort. The response rates for the 6 survey waves from 2000 to 2010 were 86%, 85%, 91%, 88%, 92%, and 85%, respectively. Table 1 presents the weighted characteristics of the cohort as a whole and by time of death. The mean age at death was 79.1 years, 54% were women, and 17% were nonwhite. Twenty-two percent were reported to have had cancer, 33% had CHF or chronic lung disease, 16% were frail, and 16% died suddenly. Fourteen percent reported none of these categories. Approximately 50% of decedents were reported to have had moderate or severe pain, depression, periodic confusion, dyspnea, or incontinence; approximately 60% were reported to have had any pain, severe fatigue, or anorexia; and approximately 12% were reported to have had frequent vomiting. Table 2 presents the adjusted prevalence of symptoms from the fully and minimally adjusted models for all decedents between 1998 and 2010; Appendix Tables 2 and 3 (available at www.annals.org) present this information for cancer, CHF or chronic lung disease, frailty, and sudden death. These estimates are largely similar between the 2 sets of models and show the high prevalence of most symptoms in the entire population and all decedent categories. Most estimates also suggest positive trends in prevalence over time. Table 3 presents the adjusted percentage of change in the prevalence of symptoms from the fully and minimally adjusted models for all decedents and for decedents in the categories of cancer, CHF or chronic lung disease, frailty, or sudden death. In the fully adjusted models, proxy reports of the prevalence of any pain (mild, moderate, or severe) increased for all decedents by 11.9% (95% CI, 3.1% to 21.4%) between 1998 and 2010. Reported prevalences of depression and periodic confusion increased for all decedents and in certain decedent categories. The prevalence of incontinence also increased for all decedents. Increasing trends in the reported prevalence of other symptoms were seen in most decedent categories but were not significant. Moderate or severe pain, severe fatigue, anorexia, and frequent vomiting did not show significant changes in any group of decedents, and there were no significant changes for cancer.
As compared with the fully adjusted models, the minimally adjusted models generally showed a larger percentage of changes in the prevalence of symptoms, and more of these changes were significant ( Table 3) . As with the fully adjusted models, there were no significant changes for cancer.
We performed 2 sensitivity analyses for the fully adjusted models: one to estimate symptom prevalence and percentage of change with the 2002 survey wave excluded (Appendix Tables 4 and 5, available at www .annals.org) and the other to investigate yearly changes rather than 12-year changes (Appendix Table 6 , available at www.annals.org). The overall results did not differ appreciably between analyses with and without the 2002 survey wave, and the magnitude and significance of the yearly changes generally comported with those of the 12-year changes. 
DISCUSSION
We analyzed interviews with bereaved family members conducted on behalf of decedents in a large, nationally representative survey to evaluate changes in end-of-life symptom burden in the United States between 1998 and 2010. Over the time frame of our study, proxy reports of many symptoms increased in prevalence, including pain, depression, and periodic confusion. Consistent with our hypothesis, we found no significant trends in any symptom among decedents with cancer.
Proxy reports of worsening symptom prevalence raise concerns about shortcomings in end-of-life care despite increasing national attention and resources devoted to it. Indeed, recent studies of health care performance suggest that persistent gaps remain in addressing symptoms near the end of life (27) (28) (29) . It is particularly concerning that proxy reports of pain have increased because pain is among the most visible and well-studied aspects of the end-of-life experience, has received policy attention, and significantly affects health-related quality of life (6) . Moderate and severe pain, for example, have a more pronounced effect on health-related quality of life than many health and sociodemographic factors (30, 31). It is encouraging, however, that trends in the prevalence and severity of cancer pain may have stabilized. This should be monitored in the face of growing public concern about prescription opioid abuse, which may create resistance to opioid use from clinicians and patients in otherwiseappropriate scenarios (32).
Our results indicate that symptom burden is high near the end of life, and our findings are generally concordant with those of population-level studies from other countries. Outpatients with cancer in Canada assessed between diagnosis and death reported prevalences of 45% to 60% for pain, dyspnea, depression, and anorexia, and 75% for fatigue (33). Dyspnea prevalence among hospice patients in Australia at 3 months before death was 50% overall, 65% for patients with heart failure, and 88% for those with end-stage pulmonary disease (34) .
Many factors might contribute to the persistence and potential increase in prevalence of these troubling end-of-life symptoms. Recent reports show that the intensity of treatment and the rate of adverse transitions have been increasing near the end of life (7). Hospice is often "tacked on" to this more intense late-life care: Although hospice use doubled from 2000 to 2009, the median stay is less than 3 weeks (7, 35) . Some patients who have short stays may not realize the full benefits of hospice for symptomatic relief. Palliative care services are more common in hospitals, and patients may not have consistent access to palliative services in outpatient, home, and long-term facility settings where most of the course of a terminal illness takes place. Effective * Analysis accounts for complex survey design. † Adjusted prevalence was estimated from regression models of each symptom on time of death, with control for age at death, sex, race/ethnicity, number of nights spent in a hospital in the last 2 y of life, nursing home residency at the time of death and length of nursing home residency before death (regardless of site of death), number of activities of daily living dependencies (dressing, walking, bathing, eating, transferring, or toileting), diagnosis of arthritis (pain models only), depression reported in interview wave before death, highest education level, household wealth, annual household income, proxy's relationship to decedent, time elapsed between decedent's death and proxy's interview, average hours of care per week given to decedent from all informal caregivers, spouse's highest education level if proxy was spouse, English/Spanish preference for interview, and year that the decedent entered the Health and Retirement Study sample. ‡ Adjusted prevalence was estimated from regression models of each symptom on time of death, with control for age at death, sex, race/ethnicity, and time elapsed between decedent's death and proxy's interview.
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interventions can sometimes mitigate the symptoms we have highlighted (for example, opioid regimens for pain and dyspnea) (36), but significant gaps remain in their delivery near the end of life (37, 38). Therefore, interventions may not be reaching the right patients in the right ways. In addition, increased attention to end-of-life care in general and symptoms specifically may have increased proxy reporting of symptoms over the time frame of our study. For example, if clinicians became more likely to ask about symptoms, proxies may have become more aware of them and thus more likely to report them.
Proxy reports inevitably reflect both the patient's and the proxy's experiences. They can provide invaluable information, but further research is needed to improve their validity, particularly with regard to the reporting of subjective symptoms, which proxies tend to overestimate (39). The evidence base is inconsistent with respect to the effect of various factors on the validity of proxy reports, including the contributions of caregiver distress and the proxy's relationship to the decedent (39). Improved understanding of proxy reports is especially important now that they are being used in hospice and other settings for quality assessment and improvement (40).
We faced several limitations. First, we used proxy reports of outcomes, which could affect the validity of subjective symptoms (39). Second, we used mostly yes/no questions, which might have masked variation in symptom intensity. Although we could not assess changes in the severity of nonpain outcomes, the increase in their reported prevalence raises concerns. Third, because of limitations in the survey itself, we could not capture all constructs relevant to evaluating symptom trends in end-of-life patients, particularly hospice enrollment and site of death. The attenuation of many of our results in fully adjusted models compared with minimally adjusted models suggests that changes in many of the proxy and decedent characteristics were partially responsible for the changes in reported symptoms we observed. It is therefore important to recognize that residual confounding may remain because of other factors we could not account for in our models.
In summary, between 1998 and 2010, proxy reports of serious pain and many other distressing symptoms became more common near the end of life. Given our knowledge of best practices and continued gaps in applying them, there is an urgent need to benchmark current practice against current knowledge. Future research should evaluate settings that provide better and worse end-of-life symptom management to offer insight into promoting best practices. Improving care at the end of life will necessitate further investment to understand the trends we identified, and steps will be required to reverse them. CHF = congestive heart failure. * Analysis accounts for complex survey design. † 1029 decedents did not qualify for placement in any of the 4 categories. ‡ Adjusted percentage of change was estimated from regression models of each symptom on time of death, with control for age at death, sex, race/ethnicity, number of nights spent in a hospital in the last 2 y of life, nursing home residency at the time of death and length of nursing home residency before death (regardless of site of death), number of activities of daily living dependencies (dressing, walking, bathing, eating, transferring, or toileting), diagnosis of arthritis (pain models only), depression reported in interview wave before death, highest education level, household wealth, annual household income, proxy's relationship to decedent, time elapsed between decedent's death and proxy's interview, average hours of care per week given to decedent from all informal caregivers, spouse's highest education level if proxy was spouse, English/Spanish preference for interview, and year that the decedent entered the Health and Retirement Study sample. CIs are bootstrapped. § Adjusted percentage of change was estimated from regression models of each symptom on time of death, with control for age at death, sex, race/ethnicity, and time elapsed between decedent's death and proxy's interview. CIs are bootstrapped. 
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